HomeTechVehicles & TransportationTSLA Stalls on China Sales, CEG Sells Off, VKTX's Promising Weight Loss Drug Trial

TSLA Stalls on China Sales, CEG Sells Off, VKTX's Promising Weight Loss Drug Trial

After Tesla's (TSLA) earnings ripped the stock to the upside, lower-than-expected EV sales in China continued a notable downtrend since its report. Constellation Energy (CEG) sold off when its guidance didn't reach expectations, while Viking Therapeutics (VKTX) rallied off positive trial results from its weight loss drug. George Tsilis dives into the morning's top stories.

Morning Trade Live

04 Nov 2024

SHARE

ON AIR
8:00 pm
Next Gen Investing
replay
12:00 am
Market Overtime
REPLAY
12:30 am
Market On Close
REPLAY
education
2:00 am
Your First Trade
REPLAY
education
2:30 am
Your First Trade
REPLAY
3:00 am
Fast Market
REPLAY
4:00 am
Next Gen Investing
REPLAY
education
5:00 am
Liz Ann Live
REPLAY
5:30 am
The Wrap
REPLAY
7:00 am
Market Overtime
REPLAY
8:00 am
Market Overtime
REPLAY
8:30 am
Market On Close
REPLAY
education
10:00 am
Schwab 2026 Outlook
REPLAY
11:00 am
Fast Market
REPLAY
12:00 pm
Next Gen Investing
REPLAY
education
1:00 pm
Liz Ann Live
REPLAY
1:30 pm
The Wrap
REPLAY
3:00 pm
Market Overtime
REPLAY
4:00 pm
Market Overtime
REPLAY
4:30 pm
Market On Close
REPLAY
education
6:00 pm
Schwab 2026 Outlook
REPLAY
7:00 pm
Fast Market
REPLAY
ON AIR
8:00 pm
Next Gen Investing
REPLAY
education
9:00 pm
Liz Ann Live
REPLAY
9:30 pm
The Wrap
REPLAY
11:00 pm
Market Overtime
REPLAY

Schwab Network's Newsletters

Daily insights for every investor